Clinical Trial Update: Early Feasibility Study (EFS) of the 'CAROL' for Treatment of Lung Cancer Stage 1 [NA]

View source ↗

Summary

An early feasibility study of the CAROL treatment for stage 1 non-small cell lung cancer is currently recruiting, sponsored by Tau Medical Australia Pty Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CAROL

Snippet

Sponsor: Tau Medical Australia Pty Ltd | Conditions: NSCLC (Non-small Cell Lung Cancer) | NA | Status: RECRUITING